Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Epidemiology (1)
  • Food allergy (14)
  • Genomics and proteomics (1)
  • Immunomodulation and nutrition (2)
  • Mastocytosis and mast cells (11)
  • Microbiome (1)
  • Pediatrics (9)
  • Prevention (2)
Poster available until
  • Until platform closure (1)
Poster categories
  • Thematic Poster Session (25)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (15)
  • x L-TPS03 (14)
  • L-TPS04 (12)
  • L-TPS05 (13)
  • L-TPS06 (8)
  • L-TPS07 (11)
  • L-TPS08 (7)
  • L-TPS09 (13)
  • L-TPS10 (13)
  • L-TPS11 (12)
  • L-TPS12 (14)
  • L-TPS13 (13)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (14)
  • L-TPS17 (13)
  • L-TPS18 (10)
  • L-TPS19 (10)
  • L-TPS20 (12)
  • L-TPS21 (12)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (14)
  • TPS04 (9)
  • TPS05 (15)
  • TPS06 (11)
  • TPS07 (13)
  • TPS08 (9)
  • TPS09 (9)
  • TPS10 (16)
  • TPS11 (13)
  • TPS12 (12)
  • TPS13 (11)
  • TPS14 (12)
  • TPS15 (15)
  • TPS16 (15)
  • TPS17 (12)
  • TPS18 (10)
  • TPS19 (7)
  • TPS20 (11)
  • TPS21 (5)
  • TPS22 (3)
  • TPS23 (4)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (16)
  • TPS30 (14)
  • TPS31 (15)
  • TPS32 (16)
  • TPS33 (14)
  • TPS34 (17)
  • TPS35 (15)
  • TPS36 (12)
  • TPS37 (15)
  • TPS38 (13)
  • TPS39 (14)
  • TPS40 (13)
  • TPS41 (9)
  • TPS42 (12)
  • TPS43 (12)
  • TPS44 (14)
  • TPS45 (12)
  • TPS46 (8)
  • TPS47 (7)
  • TPS48 (5)
  • TPS49 (5)
  • TPS51 (12)
  • TPS52 (14)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS58 (12)
  • TPS59 (13)
  • TPS60 (14)
  • TPS61 (11)
  • TPS62 (9)
  • TPS63 (10)
  • TPS64 (11)
  • TPS65 (8)
  • TPS66 (9)
  • TPS67 (9)
  • TPS68 (19)
  • TPS69 (8)
  • TPS70 (9)
  • x TPS71 (11)
  • TPS72 (6)
  • TPS73 (5)
  • TPS75 (4)
25 results
Thumbnail

D1.182 - Investigation of risk factors for the development of food-induced enterocolitis syndrome in children with a history of allergic proctocolitis caused by milk

Thumbnail

D1.184 - Evaluation of recombinant GAPDH for validation as a new apple allergen in the Mexican pediatric population

Thumbnail

D1.185 - One-day oral challenge test in low risk nut allergic children

Thumbnail

D1.186 - Reggsolving the eggnigma. Characteristics and prognosis of egg FPIES in children

Thumbnail

D1.187 - The role of gut microbiota in non-specific lipid transfer protein (nsLTP) allergies: insights from 16S rRNA gene sequencing

Thumbnail

D1.188 - Diet Diversity in Early Childhood, and Prevalence of Food Allergies in Children with Autism Spectrum Disorder

Thumbnail

D1.189 - An Analysis of Adrenaline Auto-Injector distribution in the Republic of Ireland between 2019 to 2023

Thumbnail

D1.191 - Global Survey on Healthcare Provider Practices in the Primary Prevention of Food Allergy: Implementation and Regional Gaps

Thumbnail

D1.192 - Natural Course and Predictors of Cow’s Milk Allergy Resolution in an Asian Pediatric Cohort: Data from a Tertiary Care Center

Thumbnail

D1.193 - Pumpkin Seed Allergy in Children

Thumbnail

D1.194 - Phylogenetic relationships across allergenic foods to guide the risk assessment of novel food proteins

Thumbnail

D1.195 - Immunoproteomic study of pear (Pyrus communis) in mexican population

Thumbnail

D1.196 - Characterizing the detectable milk protein allergens in milk ladder foods

Thumbnail

D1.197 - Casual consumption of small amounts of peanut in children with IgE-mediated allergy is associated with outgrowing IgE-mediated peanut allergy: results of a retrospective observational study

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Pagination

  • Current page 1
  • Page 2
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM